A869 0,9% saline on the costs of IV fluids and costs associated with fluid-related complications. The target population was adult patients (age ≥ 18 years) meeting SIRS criteria and receiving solely crystalloid IV fluids. The interventions compared were: patients mainly receiving BAL fluid mix versus patients receiving IV fluid therapy without BAL fluid mix considering an increasing adoption rate over 5-year period. Results: The base case was defined as a 300-bed hospital with 90% occupancy, a 2.7% SIRS frequency among inpatients, current BAL adoption level of 2%, projected year 5 BAL adoption levels of 20%. The patient number per month requiring fluid resuscitation calculated was 47 (564 per year). The overall savings were calculated by subtracting the costs of complications and treatments associated with BAL adoption level for a given year from costs associated with current BAL adoption level and adding the incremental costs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.